|
3.1 Tabac
|
|
|
|
|
3.1.1 Tabac - e-cigs
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
|
4.12 Biopsies liquides
|
|
|
Blood tests track lung cancer gene changes, aiding treatment [STAT]
|
|
|
|
|
|
To
be clear: This kind of care is not available yet — the tests used in
these studies are experimental and were customized in a lab to analyze
the genes in each patient’s cancer. But the technology is advancing
rapidly, and many companies are working on tests that can do this.
|
|
|
|
|
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
The top 10 pharma R&D budgets in 2016 [FierceBiotech]
|
|
|
|
|
|
On
average last year, the top 10 Big Pharmas spent just over 17% of their
top line on research, with GlaxoSmithKline spending the second least in
percentage terms at 12.9%, and the least in absolute numbers at £3.62
billion ($4.49 billion).
|
|
|
|
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
Takeda’s Ninlaro rejected by NICE for multiple myeloma [PharmaTimes]
|
|
|
|
|
|
Ninlaro
(ixazomib) plus lenalidomide and dexamethasone is authorised to treat
multiple myeloma in people who have had one or more previous therapies,
but in clinical practice is likely to be used only for those who have
had two or three previous therapies, according to the Institute.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
Pregnancy complications await childhood cancer survivors [Reuters]
|
|
|
|
|
|
Female
cancer survivors who got abdominal radiation are more than three times
more likely to develop diabetes during pregnancy as their peers who
received different tumor treatments, the study found. After radiation,
these cancer survivors are also more than twice as likely to develop
anemia during pregnancy.
|
|
|
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.11 Patients
|
|
|
|
6.12 Ethique
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
6.6 Publications
|
|
|
|
|
|
|
|
6.8 Communication
|
|
|
|
6.9 Controverses
|
|
|
|
|